Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial Meeting Abstract
| Authors: | Strickler, J. H.; Zemla, T.; Ou, F. S.; Cercek, A.; Wu, C.; Sanchez, F. A.; Hubbard, J.; Jaszewski, B.; Bandel, L.; Schweitzer, B.; Niedzwiecki, D.; Kemeny, N.; Boland, P. M.; Ng, K.; Bekaii-Saab, T. |
| Abstract Title: | Trastuzumab and tucatinib for the treatment of HER2 amplified metastatic colorectal cancer (mCRC): Initial results from the MOUNTAINEER trial |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz246.005 |
| Language: | English |
| ACCESSION: | WOS:000491295501343 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz246.005 |
| Notes: | Meeting Abstract: 527PD -- Appears on page v200 of the abstract book -- Source: Wos |
